Michele A. Kliem is a U.S. Patent Agent with extensive experience in thoughtfully developing and managing IP portfolios in biotechnology and pharmaceutical sciences and is a member of the Life Sciences team in Ballard Spahr's Patents Group. Michele prepares and prosecutes U.S. and international patent applications of academic and biotechnology start-ups.
Michele’s technical experience spans a wide range of technologies within biomedical and mechanical arts, including immunology, biotechnology, drug delivery systems, pharmaceuticals, neuroscience, drug formulations, genetics, molecular diagnostics, genome-editing, antibody engineering, medical devices, and nucleic acid- and protein-based therapeutics. She also has experience preparing infringement and validity analyses, litigation strategic planning, and filing Abbreviated New Drug Applications.
Services
Professional Highlights
Professional Activities
Society for Neuroscience
International Basal Ganglia Society
Instructor, Georgia Institute of Technology, School of Applied Physiology, 2010-2014
Publications
Michele has co-authored numerous scientific publications, including:
"Addressing Breach of Method-of-Use Patents by Generics," Law360, May 2, 2012
"Assessment of Hippocampal Adena-associated Viral Vector Gene Delivery via Frarneless Stereotaxis in a Nonhuman Primate," Stereotactic Functional Neurosurgery, 89(5):275-85, 2011
"Intramuscular Administration of a VEGF Zinc Finger Transcription Factor Activator (VEGF-ZFP-TF) Improves Functional Outcomes in SOD1 Rats," Amyotrophic Lateral Sclerosis, 12(5):331-9, 2011
Credentials
Education
Emory University (Ph.D. 2008, pharmacology)
University of Toledo (M.S. 1994, pharmaceutic science)
Ashland University (B.S. 1992, biology)
Honors Program; Recipient, Presidential Scholarship, Ohio Choice Grant, and H. Gehman Chemistry Scholarship
Admissions
U.S. Patent and Trademark Office